APO Research
Talk to an analyst

APO RESEARCH · REPORT

Glycogen Synthase Kinase 3 Beta

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Glycogen Synthase Kinase 3 Beta Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025183 pages

Choose your research edition.

Industry ResearchGlycogen Synthase Kinase 3 Beta Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Glycogen Synthase Kinase 3 Beta Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Glycogen Synthase Kinase 3 Beta Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Glycogen Synthase Kinase 3 Beta Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Glycogen Synthase Kinase 3 Beta Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Glycogen Synthase Kinase 3 Beta market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Glycogen Synthase Kinase 3 Beta is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Glycogen Synthase Kinase 3 Beta is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Glycogen Synthase Kinase 3 Beta is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Glycogen Synthase Kinase 3 Beta is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Glycogen Synthase Kinase 3 Beta include Neurim Pharmaceuticals Ltd, Mitsubishi Tanabe Pharma Corp, Jeil Pharmaceutical Co Ltd, DiaMedica Therapeutics Inc, Angelini Group, AMO Pharma Ltd and Actuate Therapeutics Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Glycogen Synthase Kinase 3 Beta market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Glycogen Synthase Kinase 3 Beta and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Glycogen Synthase Kinase 3 Beta sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Glycogen Synthase Kinase 3 Beta market size, projected growth trends, production technologies, key applications, and end-use industries.

Glycogen Synthase Kinase 3 Beta Segment by Company

Neurim Pharmaceuticals Ltd

Mitsubishi Tanabe Pharma Corp

Jeil Pharmaceutical Co Ltd

DiaMedica Therapeutics Inc

Angelini Group

AMO Pharma Ltd

Actuate Therapeutics Inc

Glycogen Synthase Kinase 3 Beta Segment by Type

Neu-120

DM-204

AP-1

AP-001

Others

Glycogen Synthase Kinase 3 Beta Segment by Application

Dyskinesia

Musculoskeletal Disorder

Lung Cancer

Menkes Disease

Others

Glycogen Synthase Kinase 3 Beta Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Glycogen Synthase Kinase 3 Beta market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Glycogen Synthase Kinase 3 Beta and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Glycogen Synthase Kinase 3 Beta.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Glycogen Synthase Kinase 3 Beta market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Glycogen Synthase Kinase 3 Beta manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Glycogen Synthase Kinase 3 Beta in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Glycogen Synthase Kinase 3 Beta in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Glycogen Synthase Kinase 3 Beta Industry Trends Table 2. Glycogen Synthase Kinase 3 Beta Industry Drivers Table 3. Glycogen Synthase Kinase 3 Beta Industry Opportunities and Challenges Table 4. Glycogen Synthase Kinase 3 Beta Industry Restraints Table 5. Global Glycogen Synthase Kinase 3 Beta Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Glycogen Synthase Kinase 3 Beta Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Glycogen Synthase Kinase 3 Beta Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Glycogen Synthase Kinase 3 Beta Sales Market Share by Manufacturers Table 9. Global Glycogen Synthase Kinase 3 Beta Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Glycogen Synthase Kinase 3 Beta Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Glycogen Synthase Kinase 3 Beta Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Glycogen Synthase Kinase 3 Beta Manufacturers, Product Type & Application Table 13. Global Glycogen Synthase Kinase 3 Beta Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Glycogen Synthase Kinase 3 Beta by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Neu-120 Table 17. Major Manufacturers of DM-204 Table 18. Major Manufacturers of AP-1 Table 19. Major Manufacturers of AP-001 Table 20. Major Manufacturers of Others Table 21. Global Glycogen Synthase Kinase 3 Beta Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global Glycogen Synthase Kinase 3 Beta Sales by Type (2021-2026) & (K Units) Table 23. Global Glycogen Synthase Kinase 3 Beta Sales by Type (2027-2032) & (K Units) Table 24. Global Glycogen Synthase Kinase 3 Beta Sales Market Share by Type (2021-2026) Table 25. Global Glycogen Synthase Kinase 3 Beta Sales Market Share by Type (2027-2032) Table 26. Global Glycogen Synthase Kinase 3 Beta Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 27. Global Glycogen Synthase Kinase 3 Beta Revenue by Type (2021-2026) & (K Units) Table 28. Global Glycogen Synthase Kinase 3 Beta Revenue by Type (2027-2032) & (K Units) Table 29. Global Glycogen Synthase Kinase 3 Beta Revenue Market Share by Type (2021-2026) Table 30. Global Glycogen Synthase Kinase 3 Beta Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Dyskinesia Table 32. Major Manufacturers of Musculoskeletal Disorder Table 33. Major Manufacturers of Lung Cancer Table 34. Major Manufacturers of Menkes Disease Table 35. Major Manufacturers of Others Table 36. Global Glycogen Synthase Kinase 3 Beta Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Glycogen Synthase Kinase 3 Beta Sales by Application (2021-2026) & (K Units) Table 38. Global Glycogen Synthase Kinase 3 Beta Sales by Application (2027-2032) & (K Units) Table 39. Global Glycogen Synthase Kinase 3 Beta Sales Market Share by Application (2021-2026) Table 40. Global Glycogen Synthase Kinase 3 Beta Sales Market Share by Application (2027-2032) Table 41. Global Glycogen Synthase Kinase 3 Beta Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 42. Global Glycogen Synthase Kinase 3 Beta Revenue by Application (2021-2026) & (K Units) Table 43. Global Glycogen Synthase Kinase 3 Beta Revenue by Application (2027-2032) & (K Units) Table 44. Global Glycogen Synthase Kinase 3 Beta Revenue Market Share by Application (2021-2026) Table 45. Global Glycogen Synthase Kinase 3 Beta Revenue Market Share by Application (2027-2032) Table 46. Global Glycogen Synthase Kinase 3 Beta Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 47. Global Glycogen Synthase Kinase 3 Beta Sales by Region (2021-2026) & (K Units) Table 48. Global Glycogen Synthase Kinase 3 Beta Sales Market Share by Region (2021-2026) Table 49. Global Glycogen Synthase Kinase 3 Beta Sales Forecasted by Region (2027-2032) & (K Units) Table 50. Global Glycogen Synthase Kinase 3 Beta Sales Forecasted Market Share by Region (2027-2032) Table 51. North America Glycogen Synthase Kinase 3 Beta Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. North America Glycogen Synthase Kinase 3 Beta Sales by Country (2021-2026) & (K Units) Table 53. North America Glycogen Synthase Kinase 3 Beta Sales by Country (2027-2032) & (K Units) Table 54. Europe Glycogen Synthase Kinase 3 Beta Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Europe Glycogen Synthase Kinase 3 Beta Sales by Country (2021-2026) & (K Units) Table 56. Europe Glycogen Synthase Kinase 3 Beta Sales by Country (2027-2032) & (K Units) Table 57. Asia Pacific Glycogen Synthase Kinase 3 Beta Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. Asia Pacific Glycogen Synthase Kinase 3 Beta Sales by Country (2021-2026) & (K Units) Table 59. Asia Pacific Glycogen Synthase Kinase 3 Beta Sales by Country (2027-2032) & (K Units) Table 60. South America, Middle East and Africa Glycogen Synthase Kinase 3 Beta Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 61. South America, Middle East and Africa Glycogen Synthase Kinase 3 Beta Sales by Country (2021-2026) & (K Units) Table 62. South America, Middle East and Africa Glycogen Synthase Kinase 3 Beta Sales by Country (2027-2032) & (K Units) Table 63. Global Glycogen Synthase Kinase 3 Beta Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 64. Global Glycogen Synthase Kinase 3 Beta Revenue by Region (2021-2026) & (US$ Million) Table 65. Global Glycogen Synthase Kinase 3 Beta Revenue by Region (2027-2032) & (US$ Million) Table 66. Global Glycogen Synthase Kinase 3 Beta Revenue Market Share by Region (2021-2026) Table 67. Global Glycogen Synthase Kinase 3 Beta Revenue Market Share by Region (2027-2032) Table 68. Neurim Pharmaceuticals Ltd Company Information Table 69. Neurim Pharmaceuticals Ltd Business Overview Table 70. Neurim Pharmaceuticals Ltd Glycogen Synthase Kinase 3 Beta Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Neurim Pharmaceuticals Ltd Glycogen Synthase Kinase 3 Beta Product Portfolio Table 72. Neurim Pharmaceuticals Ltd Recent Development Table 73. Mitsubishi Tanabe Pharma Corp Company Information Table 74. Mitsubishi Tanabe Pharma Corp Business Overview Table 75. Mitsubishi Tanabe Pharma Corp Glycogen Synthase Kinase 3 Beta Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Mitsubishi Tanabe Pharma Corp Glycogen Synthase Kinase 3 Beta Product Portfolio Table 77. Mitsubishi Tanabe Pharma Corp Recent Development Table 78. Jeil Pharmaceutical Co Ltd Company Information Table 79. Jeil Pharmaceutical Co Ltd Business Overview Table 80. Jeil Pharmaceutical Co Ltd Glycogen Synthase Kinase 3 Beta Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Jeil Pharmaceutical Co Ltd Glycogen Synthase Kinase 3 Beta Product Portfolio Table 82. Jeil Pharmaceutical Co Ltd Recent Development Table 83. DiaMedica Therapeutics Inc Company Information Table 84. DiaMedica Therapeutics Inc Business Overview Table 85. DiaMedica Therapeutics Inc Glycogen Synthase Kinase 3 Beta Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. DiaMedica Therapeutics Inc Glycogen Synthase Kinase 3 Beta Product Portfolio Table 87. DiaMedica Therapeutics Inc Recent Development Table 88. Angelini Group Company Information Table 89. Angelini Group Business Overview Table 90. Angelini Group Glycogen Synthase Kinase 3 Beta Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Angelini Group Glycogen Synthase Kinase 3 Beta Product Portfolio Table 92. Angelini Group Recent Development Table 93. AMO Pharma Ltd Company Information Table 94. AMO Pharma Ltd Business Overview Table 95. AMO Pharma Ltd Glycogen Synthase Kinase 3 Beta Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. AMO Pharma Ltd Glycogen Synthase Kinase 3 Beta Product Portfolio Table 97. AMO Pharma Ltd Recent Development Table 98. Actuate Therapeutics Inc Company Information Table 99. Actuate Therapeutics Inc Business Overview Table 100. Actuate Therapeutics Inc Glycogen Synthase Kinase 3 Beta Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Actuate Therapeutics Inc Glycogen Synthase Kinase 3 Beta Product Portfolio Table 102. Actuate Therapeutics Inc Recent Development Table 103. Key Raw Materials Table 104. Raw Materials Key Suppliers Table 105. Glycogen Synthase Kinase 3 Beta Distributors List Table 106. Glycogen Synthase Kinase 3 Beta Customers List Table 107. Research Programs/Design for This Report Table 108. Authors List of This Report Table 109. Secondary Sources Table 110. Primary Sources List of Figures Figure 1. Glycogen Synthase Kinase 3 Beta Product Image Figure 2. Global Glycogen Synthase Kinase 3 Beta Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Glycogen Synthase Kinase 3 Beta Market Size (2021-2032) & (US$ Million) Figure 4. Global Glycogen Synthase Kinase 3 Beta Sales (2021-2032) & (K Units) Figure 5. Global Glycogen Synthase Kinase 3 Beta Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Glycogen Synthase Kinase 3 Beta Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Neu-120 Image Figure 9. DM-204 Image Figure 10. AP-1 Image Figure 11. AP-001 Image Figure 12. Others Image Figure 13. Global Glycogen Synthase Kinase 3 Beta Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Glycogen Synthase Kinase 3 Beta Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Glycogen Synthase Kinase 3 Beta Sales Market Share by Type (2021-2032) Figure 16. Global Glycogen Synthase Kinase 3 Beta Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 17. Global Glycogen Synthase Kinase 3 Beta Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Glycogen Synthase Kinase 3 Beta Revenue Market Share by Type (2021-2032) Figure 19. Dyskinesia Image Figure 20. Musculoskeletal Disorder Image Figure 21. Lung Cancer Image Figure 22. Menkes Disease Image Figure 23. Others Image Figure 24. Global Glycogen Synthase Kinase 3 Beta Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Glycogen Synthase Kinase 3 Beta Sales Market Share 2021 VS 2025 VS 2032 Figure 26. Global Glycogen Synthase Kinase 3 Beta Sales Market Share by Application (2021-2032) Figure 27. Global Glycogen Synthase Kinase 3 Beta Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 28. Global Glycogen Synthase Kinase 3 Beta Revenue Market Share 2021 VS 2025 VS 2032 Figure 29. Global Glycogen Synthase Kinase 3 Beta Revenue Market Share by Application (2021-2032) Figure 30. North America Glycogen Synthase Kinase 3 Beta Sales and Growth Rate (2021-2032) & (K Units) Figure 31. North America Glycogen Synthase Kinase 3 Beta Sales Market Share by Country (2021-2032) Figure 32. U.S. Glycogen Synthase Kinase 3 Beta Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Canada Glycogen Synthase Kinase 3 Beta Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Mexico Glycogen Synthase Kinase 3 Beta Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Europe Glycogen Synthase Kinase 3 Beta Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Europe Glycogen Synthase Kinase 3 Beta Sales Market Share by Country (2021-2032) Figure 37. Germany Glycogen Synthase Kinase 3 Beta Sales and Growth Rate (2021-2032) & (K Units) Figure 38. France Glycogen Synthase Kinase 3 Beta Sales and Growth Rate (2021-2032) & (K Units) Figure 39. U.K. Glycogen Synthase Kinase 3 Beta Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Italy Glycogen Synthase Kinase 3 Beta Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Netherlands Glycogen Synthase Kinase 3 Beta Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Asia Pacific Glycogen Synthase Kinase 3 Beta Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Asia Pacific Glycogen Synthase Kinase 3 Beta Sales Market Share by Country (2021-2032) Figure 44. China Glycogen Synthase Kinase 3 Beta Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Japan Glycogen Synthase Kinase 3 Beta Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South Korea Glycogen Synthase Kinase 3 Beta Sales and Growth Rate (2021-2032) & (K Units) Figure 47. Southeast Asia Glycogen Synthase Kinase 3 Beta Sales and Growth Rate (2021-2032) & (K Units) Figure 48. India Glycogen Synthase Kinase 3 Beta Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Australia Glycogen Synthase Kinase 3 Beta Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South America, Middle East and Africa Glycogen Synthase Kinase 3 Beta Sales and Growth Rate (2021-2032) & (K Units) Figure 51. South America, Middle East and Africa Glycogen Synthase Kinase 3 Beta Sales Market Share by Country (2021-2032) Figure 52. Brazil Glycogen Synthase Kinase 3 Beta Sales and Growth Rate (2021-2032) & (K Units) Figure 53. South Africa Glycogen Synthase Kinase 3 Beta Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Saudi Arabia Glycogen Synthase Kinase 3 Beta Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Turkey Glycogen Synthase Kinase 3 Beta Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Argentina Glycogen Synthase Kinase 3 Beta Sales and Growth Rate (2021-2032) & (K Units) Figure 57. UAE Glycogen Synthase Kinase 3 Beta Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Egypt Glycogen Synthase Kinase 3 Beta Sales and Growth Rate (2021-2032) & (K Units) Figure 59. Chile Glycogen Synthase Kinase 3 Beta Sales and Growth Rate (2021-2032) & (K Units) Figure 60. Global Glycogen Synthase Kinase 3 Beta Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 61. Global Glycogen Synthase Kinase 3 Beta Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 62. North America Glycogen Synthase Kinase 3 Beta Revenue (2021-2032) & (US$ Million) Figure 63. North America Glycogen Synthase Kinase 3 Beta Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Europe Glycogen Synthase Kinase 3 Beta Revenue (2021-2032) & (US$ Million) Figure 65. Europe Glycogen Synthase Kinase 3 Beta Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Asia-Pacific Glycogen Synthase Kinase 3 Beta Revenue (2021-2032) & (US$ Million) Figure 67. Asia-Pacific Glycogen Synthase Kinase 3 Beta Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. South America, Middle East and Africa Glycogen Synthase Kinase 3 Beta Revenue (2021-2032) & (US$ Million) Figure 69. South America, Middle East and Africa Glycogen Synthase Kinase 3 Beta Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 70. Glycogen Synthase Kinase 3 Beta Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Glycogen Synthase Kinase 3 Beta Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Neu-120
  • DM-204
  • AP-1
  • AP-001
  • Others
Applications
  • Dyskinesia
  • Musculoskeletal Disorder
  • Lung Cancer
  • Menkes Disease
  • Others
Companies covered
  • Neurim Pharmaceuticals Ltd
  • Mitsubishi Tanabe Pharma Corp
  • Jeil Pharmaceutical Co Ltd
  • DiaMedica Therapeutics Inc
  • Angelini Group
  • AMO Pharma Ltd
  • Actuate Therapeutics Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Glycogen Synthase Kinase 3 Beta Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Glycogen Synthase Kinase 3 Beta Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Glycogen Synthase Kinase 3 Beta Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Glycogen Synthase Kinase 3 Beta Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Glycogen Synthase Kinase 3 Beta Market Dynamics
  1. 2.1 Glycogen Synthase Kinase 3 Beta Industry Trends
  2. 2.2 Glycogen Synthase Kinase 3 Beta Industry Drivers
  3. 2.3 Glycogen Synthase Kinase 3 Beta Industry Opportunities and Challenges
  4. 2.4 Glycogen Synthase Kinase 3 Beta Industry Restraints
3 Glycogen Synthase Kinase 3 Beta Market by Manufacturers
  1. 3.1 Global Glycogen Synthase Kinase 3 Beta Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Glycogen Synthase Kinase 3 Beta Sales by Manufacturers (2021-2026)
  3. 3.3 Global Glycogen Synthase Kinase 3 Beta Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Glycogen Synthase Kinase 3 Beta Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Glycogen Synthase Kinase 3 Beta Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Glycogen Synthase Kinase 3 Beta Manufacturers, Product Type & Application
  7. 3.7 Global Glycogen Synthase Kinase 3 Beta Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Glycogen Synthase Kinase 3 Beta Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Glycogen Synthase Kinase 3 Beta Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Glycogen Synthase Kinase 3 Beta Tier 1, Tier 2, and Tier 3
4 Glycogen Synthase Kinase 3 Beta Market by Type
  1. 4.1 Glycogen Synthase Kinase 3 Beta Type Introduction
  2. 4.1.1 Neu-120
  3. 4.1.2 DM-204
  4. 4.1.3 AP-1
  5. 4.1.4 AP-001
  6. 4.1.5 Others
  7. 4.2 Global Glycogen Synthase Kinase 3 Beta Sales by Type
  8. 4.2.1 Global Glycogen Synthase Kinase 3 Beta Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Glycogen Synthase Kinase 3 Beta Sales by Type (2021-2032)
  10. 4.2.3 Global Glycogen Synthase Kinase 3 Beta Sales Market Share by Type (2021-2032)
  11. 4.3 Global Glycogen Synthase Kinase 3 Beta Revenue by Type
  12. 4.3.1 Global Glycogen Synthase Kinase 3 Beta Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Glycogen Synthase Kinase 3 Beta Revenue by Type (2021-2032)
  14. 4.3.3 Global Glycogen Synthase Kinase 3 Beta Revenue Market Share by Type (2021-2032)
5 Glycogen Synthase Kinase 3 Beta Market by Application
  1. 5.1 Glycogen Synthase Kinase 3 Beta Application Introduction
  2. 5.1.1 Dyskinesia
  3. 5.1.2 Musculoskeletal Disorder
  4. 5.1.3 Lung Cancer
  5. 5.1.4 Menkes Disease
  6. 5.1.5 Others
  7. 5.2 Global Glycogen Synthase Kinase 3 Beta Sales by Application
  8. 5.2.1 Global Glycogen Synthase Kinase 3 Beta Sales by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Glycogen Synthase Kinase 3 Beta Sales by Application (2021-2032)
  10. 5.2.3 Global Glycogen Synthase Kinase 3 Beta Sales Market Share by Application (2021-2032)
  11. 5.3 Global Glycogen Synthase Kinase 3 Beta Revenue by Application
  12. 5.3.1 Global Glycogen Synthase Kinase 3 Beta Revenue by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Glycogen Synthase Kinase 3 Beta Revenue by Application (2021-2032)
  14. 5.3.3 Global Glycogen Synthase Kinase 3 Beta Revenue Market Share by Application (2021-2032)
6 Global Glycogen Synthase Kinase 3 Beta Sales by Region
  1. 6.1 Global Glycogen Synthase Kinase 3 Beta Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Glycogen Synthase Kinase 3 Beta Sales by Region (2021-2032)
  3. 6.2.1 Global Glycogen Synthase Kinase 3 Beta Sales by Region (2021-2026)
  4. 6.2.2 Global Glycogen Synthase Kinase 3 Beta Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Glycogen Synthase Kinase 3 Beta Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Glycogen Synthase Kinase 3 Beta Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Glycogen Synthase Kinase 3 Beta Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Glycogen Synthase Kinase 3 Beta Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Glycogen Synthase Kinase 3 Beta Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Glycogen Synthase Kinase 3 Beta Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Glycogen Synthase Kinase 3 Beta Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Glycogen Synthase Kinase 3 Beta Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Glycogen Synthase Kinase 3 Beta Revenue by Region
  1. 7.1 Global Glycogen Synthase Kinase 3 Beta Revenue by Region
  2. 7.1.1 Global Glycogen Synthase Kinase 3 Beta Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Glycogen Synthase Kinase 3 Beta Revenue by Region (2021-2026)
  4. 7.1.3 Global Glycogen Synthase Kinase 3 Beta Revenue by Region (2027-2032)
  5. 7.1.4 Global Glycogen Synthase Kinase 3 Beta Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Glycogen Synthase Kinase 3 Beta Revenue (2021-2032)
  8. 7.2.2 North America Glycogen Synthase Kinase 3 Beta Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Glycogen Synthase Kinase 3 Beta Revenue (2021-2032)
  11. 7.3.2 Europe Glycogen Synthase Kinase 3 Beta Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Glycogen Synthase Kinase 3 Beta Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Glycogen Synthase Kinase 3 Beta Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Glycogen Synthase Kinase 3 Beta Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Glycogen Synthase Kinase 3 Beta Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Neurim Pharmaceuticals Ltd
  2. 8.1.1 Neurim Pharmaceuticals Ltd Company Information
  3. 8.1.2 Neurim Pharmaceuticals Ltd Business Overview
  4. 8.1.3 Neurim Pharmaceuticals Ltd Glycogen Synthase Kinase 3 Beta Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Neurim Pharmaceuticals Ltd Glycogen Synthase Kinase 3 Beta Product Portfolio
  6. 8.1.5 Neurim Pharmaceuticals Ltd Recent Developments
  7. 8.2 Mitsubishi Tanabe Pharma Corp
  8. 8.2.1 Mitsubishi Tanabe Pharma Corp Company Information
  9. 8.2.2 Mitsubishi Tanabe Pharma Corp Business Overview
  10. 8.2.3 Mitsubishi Tanabe Pharma Corp Glycogen Synthase Kinase 3 Beta Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Mitsubishi Tanabe Pharma Corp Glycogen Synthase Kinase 3 Beta Product Portfolio
  12. 8.2.5 Mitsubishi Tanabe Pharma Corp Recent Developments
  13. 8.3 Jeil Pharmaceutical Co Ltd
  14. 8.3.1 Jeil Pharmaceutical Co Ltd Company Information
  15. 8.3.2 Jeil Pharmaceutical Co Ltd Business Overview
  16. 8.3.3 Jeil Pharmaceutical Co Ltd Glycogen Synthase Kinase 3 Beta Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Jeil Pharmaceutical Co Ltd Glycogen Synthase Kinase 3 Beta Product Portfolio
  18. 8.3.5 Jeil Pharmaceutical Co Ltd Recent Developments
  19. 8.4 DiaMedica Therapeutics Inc
  20. 8.4.1 DiaMedica Therapeutics Inc Company Information
  21. 8.4.2 DiaMedica Therapeutics Inc Business Overview
  22. 8.4.3 DiaMedica Therapeutics Inc Glycogen Synthase Kinase 3 Beta Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 DiaMedica Therapeutics Inc Glycogen Synthase Kinase 3 Beta Product Portfolio
  24. 8.4.5 DiaMedica Therapeutics Inc Recent Developments
  25. 8.5 Angelini Group
  26. 8.5.1 Angelini Group Company Information
  27. 8.5.2 Angelini Group Business Overview
  28. 8.5.3 Angelini Group Glycogen Synthase Kinase 3 Beta Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Angelini Group Glycogen Synthase Kinase 3 Beta Product Portfolio
  30. 8.5.5 Angelini Group Recent Developments
  31. 8.6 AMO Pharma Ltd
  32. 8.6.1 AMO Pharma Ltd Company Information
  33. 8.6.2 AMO Pharma Ltd Business Overview
  34. 8.6.3 AMO Pharma Ltd Glycogen Synthase Kinase 3 Beta Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 AMO Pharma Ltd Glycogen Synthase Kinase 3 Beta Product Portfolio
  36. 8.6.5 AMO Pharma Ltd Recent Developments
  37. 8.7 Actuate Therapeutics Inc
  38. 8.7.1 Actuate Therapeutics Inc Company Information
  39. 8.7.2 Actuate Therapeutics Inc Business Overview
  40. 8.7.3 Actuate Therapeutics Inc Glycogen Synthase Kinase 3 Beta Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Actuate Therapeutics Inc Glycogen Synthase Kinase 3 Beta Product Portfolio
  42. 8.7.5 Actuate Therapeutics Inc Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Glycogen Synthase Kinase 3 Beta Value Chain Analysis
  2. 9.1.1 Glycogen Synthase Kinase 3 Beta Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Glycogen Synthase Kinase 3 Beta Production Mode & Process
  6. 9.2 Glycogen Synthase Kinase 3 Beta Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Glycogen Synthase Kinase 3 Beta Distributors
  9. 9.2.3 Glycogen Synthase Kinase 3 Beta Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst